The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Megace 40 mg/ml Oral Suspension

Lexon Pharmaceuticals (Ireland) LimitedPPA23176/027/001

Main Information

Trade NameMegace 40 mg/ml Oral Suspension
Active SubstancesMegestrol acetate
Dosage FormOral suspension
Licence HolderLexon Pharmaceuticals (Ireland) Limited
Licence NumberPPA23176/027/001

Group Information

ATC CodeL02AB Progestogens
L02AB01 megestrol


License statusAuthorised
Licence Issued03/07/2020
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back